BEAM vs EW · rev $63.5M vs P/E 47, rev $1.39B
Beam Therapeutics Inc (BEAM) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BEAM currently screens at market cap $2.01B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BEAM and EW stock pages for the full models.
Not investment advice.